The FDA has granted marketing approval for the device in the US market where we expect to launch the product during the next ASPEN 2020 Nutrition conference taking place in Tampa, FL on March 28-31. Q-NRG is a result of COSMED’s collaboration with world-class institutes in the field of nutrition support in intensive care units. Product concept and specifications have been designed together with...

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination.We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation. Supporting our people and communitiesCOSMED has always been committed to its employees...

COSMED Srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced an agreement to commercialize Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry technology. The agreement provides that Baxter will bring Q-NRG+ to 18 key countries around...

Rome (Italy) - March 2018 - COSMED, world-wide leader in the design of metabolic systems for clinical and human performance applications, announced today the release of a new product line of metabolic monitors for quick, accurate, intuitive and affordable indirect calorimetry. Q-NRG is the ultimate tool to understand how to support a patient according to his/her real energy requirement, to help...